Atrasentan in Patients With IgA Nephropathy
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Christopher Carlos
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Christopher Carlos
Dr. Christopher Carlos is an Assistant Professor within the Division of Nephrology and a board-certified nephrologist. He practices both inpatient and outpatient nephrology. In his outpatient clinic, he specializes in treating patients with acute kidney injury, chronic kidney disease, end-stage kidney disease, hypertension, electrolyte imbalances and glomerular disorders.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Chinook Therapeutics U.S., Inc.
- Links
- Study Website
- ID
- NCT04573478
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 380 study participants
- Last Updated